2 days ago · WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's disease have taken an hit.. A new study found that a drug in the same class called exenatide, marketed as Byetta, had no effect on slowing the disease or easing its symtoms.. The trial, published Feb. 4 in The Lancet, followed 194 people with Parkinson's disease for 96 weeks.

2 days ago · WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's disease have taken an hit.

1 day ago · A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people with Parkinson’s disease, according to a new study. Researchers ...

2 days ago · A rigorous study that randomly assigned Parkinson’s patients to take exenatide, a relative of Ozempic, showed absolutely no benefit or slowing of the course of the degenerative disease after 96 ...

Jan 21, 2025 · Emerging research suggests a potential link between the brain's decreased sensitivity to the hormone insulin and the progression of Parkinson's. This observation has prompted researchers to investigate whether anti-diabetic medications that help manage insulin levels could potentially slow the progression of Parkinson's.

Apr 3, 2024 · Now, nearly 200 years since Parkinson expressed his hope, and after four decades of unsuccessful clinical trials, a group of French researchers reports the first glimmer of success — a modest...

Jul 1, 2024 · In this latest study, the drug, manufactured by Sanofi, helped slow the progression of motor disability after 12 months in people in an early stage of Parkinson’s disease.

May 6, 2024 · The researchers found that an older diabetes drug, which is a precursor to Ozempic, may have a protective effect on the nervous system in people living with early-stage Parkinson's disease. This recent study builds on previous research that was conducted in mice.

Apr 6, 2024 · An Ozempic-like drug used to treat diabetes, called lixisenatide, helped slow the progression of motor disability in patients in an early stage of Parkinson's disease, according to the results...

THURSDAY, April 4, 2024 -- Could a medication similar to the blockbuster weight-loss drugs Ozempic and Wegovy slow the ravages of Parkinson's disease? A new, small study suggests it could: Over the course of a year, a group of French researchers followed 156 people with early Parkinson’s who were randomly given lixisenatide , a GLP-1 receptor ...